Endoscopic Ultrasonography‐Guided Gastroenterostomy Is More Cost Effective Than Surgical Gastrojejunostomy: A Health‐Economic Evaluation Alongside a Randomized Trial
United European Gastroenterology Journal · 2026-06 · 14 (5)
DOI: 10.1002/ueg2.70220 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift United European Gastroenterology Journal, online erschienen am 05.06.2026. Verfasst von Yorick L van de Pavert und 32 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht, the Netherlands. Hauptthemen laut MEDLINE: Endosonography, Gastric Bypass, Gastric Outlet Obstruction, Gastroenterostomy. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: KWF Kankerbestrijding.
Abstract (Originalsprache)
Background
There is a paucity of data on the cost‐utility of endoscopic ultrasonography‐guided gastroenterostomy (EUS‐GE) compared with surgical gastrojejunostomy (SGJ) as palliative treatment of malignant gastric outlet obstruction.
Methods
In the ENDURO trial, 98 patients with malignant gastric outlet obstruction from 12 Dutch hospitals were randomized between EUS‐GE ( N = 48) and SGJ ( N = 50). Cost utility was evaluated from a healthcare perspective with a time horizon of 1 month. A bottom‐up approach was used to calculate the costs of each intervention, including the per‐minute price of the endoscopy and operating room (OR), considering personnel, construction, inventory and overhead costs. Other in‐hospital costs were calculated using insurance claim data. Effectiveness was displayed as quality‐adjusted life years (QALY). Bootstrapping was performed to estimate uncertainty.
Results
The calculated per‐minute price for the endoscopy room was €8.64 (US $9.34). The per‐minute price for an OR was €11.78 (US $12.74). The mean intervention costs were estimated at €4405.40 (US $4762.68) for EUS‐GE and €3393.71 (US $3668.93) for SGJ. Mean total in‐hospital costs were lower following EUS‐GE (€5172 [US $5591]) than after SGJ (€10,458 [US $11,306]), mainly due to a shorter length of hospital stay following EUS‐GE. Bootstrapping showed that 99.9% of iterations resulted in lower costs for EUS‐GE. Mean difference in 1‐month QALY contribution was 0.004 in favor of EUS‐GE. Most iterations fall within the bottom right quadrant (95.6%) of the cost‐effectiveness plane, indicating lower costs and improved QALY contribution for EUS‐GE.
Discussion
In this study, EUS‐GE was more cost effective than SGJ. The additional intervention costs were clearly outweighed by a decrease in in‐hospital costs after the procedure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht, the Netherlands.
- Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
- Department of Surgery, and Cancer Center Amsterdam, Amsterdam UMC, Location University of Amsterdam, Amsterdam, the Netherlands.
- Department of Gastroenterology and Hepatology, Martini Hospital, Groningen, the Netherlands.
- Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, the Netherlands.
- Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, the Netherlands.
ORCID-Profile: Yorick L van de Pavert, Kirsten Opmeer, Marc G Besselink, Rina Bijlsma, Jurjen J Boonstra, Judith Boot, Marco J Bruno, Olivier R Busch, Freek Daams, Paul Fockens, Janine B Kastelijn, Bas Groot Koerkamp, Jeroen Hagendoorn, Jeanin E van Hooft, Akin Inderson, Willem J Lammers, Daan J Lips, J Sven D Mieog, I Quintus Molenaar, Niels G Venneman, Robert C Verdonk, Rogier P Voermans, Roy L J van Wanrooij, Paco M J Welsing, Thomas R de Wijkerslooth, Hjalmar C van Santvoort, Leon M G Moons, Frank P Vleggaar
Förderung
- KWF Kankerbestrijding
Zitieren
APA
van de Pavert, Y. L., Opmeer, K., Besselink, M. G., Bijlsma, R., Booij, D. C., Boonstra, J. J., Boot, J., Bruno, M. J., Busch, O. R., Daams, F., Derksen, W. J. M., Fockens, P., Kastelijn, J. B., Koerkamp, B. G., Hagendoorn, J., van Hooft, J. E., Inderson, A., Lammers, W. J., Lips, D. J., …, & Dutch Pancreatic Cancer Group (2026). Endoscopic Ultrasonography‐Guided Gastroenterostomy Is More Cost Effective Than Surgical Gastrojejunostomy: A Health‐Economic Evaluation Alongside a Randomized Trial. United European Gastroenterology Journal, 14(5). https://doi.org/10.1002/ueg2.70220
Vancouver
van de Pavert YL, Opmeer K, Besselink MG, Bijlsma R, Booij DC, Boonstra JJ, et al. Endoscopic Ultrasonography‐Guided Gastroenterostomy Is More Cost Effective Than Surgical Gastrojejunostomy: A Health‐Economic Evaluation Alongside a Randomized Trial. United European Gastroenterology Journal. 2026;14(5). doi:10.1002/ueg2.70220
BibTeX
@article{vandePavert2026,
author = {van de Pavert, Yorick L and Opmeer, Kirsten and Besselink, Marc G and Bijlsma, Rina and Booij, Dieke C and Boonstra, Jurjen J and Boot, Judith and Bruno, Marco J and Busch, Olivier R and Daams, Freek and Derksen, Wouter J M and Fockens, Paul and Kastelijn, Janine B and Koerkamp, Bas Groot and Hagendoorn, Jeroen and van Hooft, Jeanin E and Inderson, Akin and Lammers, Willem J and Lips, Daan J and Mieog, J Sven D and Molenaar, I Quintus and Veenhof, Alexander A F A and Venneman, Niels G and Verdonk, Robert C and Voermans, Rogier P and van Wanrooij, Roy L J and Welsing, Paco M J and de Wijkerslooth, Thomas R and van Santvoort, Hjalmar C and Moons, Leon M G and van der Meulen, Miriam P and Vleggaar, Frank P and Dutch Pancreatic Cancer Group, Dutch Pancreatic Cancer Group},
title = {Endoscopic Ultrasonography‐Guided Gastroenterostomy Is More Cost Effective Than Surgical Gastrojejunostomy: A Health‐Economic Evaluation Alongside a Randomized Trial},
journal = {United European Gastroenterology Journal},
year = {2026},
volume = {14},
number = {5},
doi = {10.1002/ueg2.70220}
}
EUVIMED